However, clinical practice guidelines do not specifically address the issue of VTE prophylaxis in patients with cirrhosis and elevated INR values.

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

Overall, 92% of patients in group 3 were provided some form of VTE prophylaxis ( Table 4 ). This represents better than a 2.7-fold increase in VTE prophylaxis as compared with groups 1 and 2 (34% ...

Introduction Patients with an intracerebral haemorrhage are at increased risk of venous thromboembolism. Pharmacotherapy and pneumatic compression devices are capable of preventing venous ...

Objective To examine patients' understanding of hospital-associated thrombosis, and their experiences of thromboprophylaxis. Design Qualitative study using semi-structured interviews with 31 patients ...

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among hospitalised medical patients. Ongoing efforts to refine risk assessment and optimise prophylactic ...

The US Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for sexually acquired HIV.

Here’s the good news: Unlike restaurants, your office has U.S. Centers for Disease Control and Prevention (CDC) guidelines, U.S. Occupational Safety and Health Administration (OSHA) requirements, and ...

The new and updated pediatric VTE clinical guidelines incorporate the latest research in the field and mark the first update to the guidelines since their publication in 2018. In total, 16 ...

ECIL regularly updates its guidelines based on emerging evidence, with significant revisions for adult and pediatric antifungal prophylaxis introduced in 2013, 2015, and 2021.